Reported Oct 26, 2016 · Terminated

Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent…

Supernus Pharmaceuticals, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Supernus Pharmaceuticals, Inc. · 1550 E Gude Dr · Rockville, MD · 20850-1339

Is this the product you have?

  • Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only
  • Manufactured byCatalent Pharma Solutions, Winchester, KY 40391
  • Manufactured forSupernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15
Lot codes and dates
    • Lot # 426636
    • Exp 4/22/18
Amount recalled
17,128 (30-count blister packs)

Where it was sold

  • Nationwide

Why it was recalled

Superpotent Drug: Failure of assay specifications in the capsule.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Supernus Pharmaceuticals, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 26, 2019 · Data as of Sep 19, 3:29 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.